-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, V/M1VkcSOth2TRlKlWLL2cGYZqp9k11m9yW9B1d+s4m6BtrjC+djPjlNHhHwDZMy NH0S4grVaX26ZvIS8YiPDw== 0001209191-05-046232.txt : 20050907 0001209191-05-046232.hdr.sgml : 20050907 20050907145203 ACCESSION NUMBER: 0001209191-05-046232 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20050902 FILED AS OF DATE: 20050907 DATE AS OF CHANGE: 20050907 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NOVARTIS AG CENTRAL INDEX KEY: 0001114448 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-49839 FILM NUMBER: 051072558 BUSINESS ADDRESS: STREET 1: LICHSTRASSE 35 CITY: BASEL SWITZERLAND STATE: V8 ZIP: CH 4056 MAIL ADDRESS: STREET 1: LICHSTRASSE 35 CITY: BASEL SWITZERLAND ZIP: CH 4056 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDENIX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001093649 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450478605 BUSINESS ADDRESS: STREET 1: 60 HAMPSHIRE STREET STREET 2: . CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: (617) 250-3100 MAIL ADDRESS: STREET 1: 60 HAMPSHIRE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: NOVIRIO PHARMACEUTICALS LTD DATE OF NAME CHANGE: 19990820 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NOVARTIS PHARMA AG CENTRAL INDEX KEY: 0001030617 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-49839 FILM NUMBER: 051072557 BUSINESS ADDRESS: STREET 1: LICHTSTRASSE 35 STREET 2: CH-4002 CITY: BASEL STATE: V8 BUSINESS PHONE: 212-830-2474 MAIL ADDRESS: STREET 1: LICHTSTRASSE 35 STREET 2: CH-4002 CITY: BASEL STATE: V8 FORMER NAME: FORMER CONFORMED NAME: NOVARTIS INC DATE OF NAME CHANGE: 19970114 4 1 y12462_nova.xml MAIN DOCUMENT DESCRIPTION X0202 4 2005-09-02 0001093649 IDENIX PHARMACEUTICALS INC IDIX 0001114448 NOVARTIS AG LICHSTRASSE 35 CH 4002, BASEL, SWITZERLAND 0 0 1 0 0001030617 NOVARTIS PHARMA AG LICHSTRASSE 35 CH 4002, BASEL, SWITZERLAND 0 0 1 0 Common Stock 2005-09-02 4 A 0 1187093 20.18 A 27356739 I See Footnote. Novartis Pharma AG, acquired directly from Novartis BioVentures Ltd. 1,187,093 shares for $20.18 per share. Each of Novartis Pharma AG and Novartis Bioventures Ltd. are wholly-owned subsidiaries of Novartis AG. Following this transaction, Novartis AG is the indirect beneficial owner of 27,356,739 shares which are owned directly by Novartis Pharma AG. /s/ Peter Rupprecht (authorized signatory) 2005-09-02 /s/ George Miller (authorized signatory) 2005-09-02 EX-99 2 ex99.txt ADDITIONAL EXHIBITS Exhibit 99 Form 4 Joint Filer Information Additional Reporting Person: Novartis Pharma AG Address: Lichstrasse 35 CH-4002, Basel Switzerland Designated Filer: Novartis AG Issuer and Ticker Symbol: Idenix Pharmaceuticals, Inc. (IDIX) Date of Event Requiring Statement: September 2, 2005 Novartis Pharma AG By: /s/ Robert E. Pelzer September 2, 2005 --------------------- ----------------- Name: Robert E. Pelzer Date Title: General Counsel By: /s/ Joseph E. Mamie September 2, 2005 ------------------------------- ----------------- Name: Joseph E. Mamie Date Title: Head Operational Treasury -----END PRIVACY-ENHANCED MESSAGE-----